ASN
CMMB

Advisory Services Network’s Chemomab Therapeutics CMMB Stock Holding History

Advisory Services Network’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,197
Closed -$2.44K – 1852
2023
Q4 		$2.44K Sell
1,197
-1,596
-57% -$4.2K ﹤0.01% 3349
2023
Q3 		$10K Hold
2,793
– – ﹤0.01% 1466
2023
Q2 		$14.7K Hold
2,793
– – ﹤0.01% 1427
2023
Q1 		$17.8K Hold
2,793
– – ﹤0.01% 2619
2022
Q4 		$35.8K Hold
2,793
– – ﹤0.01% 2153
2022
Q3 		$28K Hold
2,793
– – ﹤0.01% 1325
2022
Q2 		$41K Buy
+2,793
New +$38.9K ﹤0.01% 1342

Other funds holding CMMB

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return